Pages that link to "Q72056212"
The following pages link to Kinetics of citalopram in test animals; drug exposure in safety studies (Q72056212):
Displaying 29 items.
- In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats (Q28363020) (← links)
- Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB (Q33828983) (← links)
- Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. (Q34586631) (← links)
- Delayed pharmacological effects of antidepressants (Q34622367) (← links)
- Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. (Q35944846) (← links)
- Differential effects of acute and repeated citalopram in mouse models of anxiety and depression (Q36822753) (← links)
- Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs (Q37417085) (← links)
- Citalopram and cardiac toxicity (Q38045165) (← links)
- Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). (Q38652284) (← links)
- Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity (Q40088615) (← links)
- Facilitation of serotonin signaling by SSRIs is attenuated by social isolation. (Q42088160) (← links)
- Stereoselective single-dose kinetics of citalopram and its metabolites in rats (Q42164280) (← links)
- Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain (Q42513314) (← links)
- The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram (Q42521024) (← links)
- Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. (Q44085203) (← links)
- Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain (Q44195703) (← links)
- Routine Therapeutic Drug Monitoring in Patients Treated with 10-360 mg/day Citalopram (Q44595729) (← links)
- Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter (Q46609585) (← links)
- Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities (Q48560883) (← links)
- Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra (Q48869870) (← links)
- Antidepressant response to chronic citalopram treatment in eight inbred mouse strains (Q48943165) (← links)
- Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels (Q69908553) (← links)
- Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram (Q70486519) (← links)
- Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram (Q70516340) (← links)
- 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram (Q71523998) (← links)
- Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo (Q73118031) (← links)
- Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram (Q73807941) (← links)
- Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram (Q73871190) (← links)
- Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats (Q91718128) (← links)